Subscribe To

Price Alert Latest News Economic Calendar News

SWAV / 3 Sizzling Growth Stocks to Buy for 2023's Second Half

As we enter the final month of the first half of the year, investors' focus is on the next six months and beyond. As a result, you might be on the hunt for the best growth stocks for the second half of 2023. Read More

Demo Live Account See Partner Details

Content Topics

Sizzling

Growth

Stocks

2023

Second

Half

2023 s

Stock

SWAV

Posted: May 31 2023, 08:00

Author Name: InvestorPlace

SWAV News

By Zacks Investment Research
November 3, 2023

Should You Buy ShockWave Medical (SWAV) Ahead of Earnings?

ShockWave Medical (SWAV) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

By Zacks Investment Research
November 1, 2023

Shockwave Medical (SWAV) Just Overtook the 20-Day Moving Average

After reaching an important support level, Shockwave Medical (SWAV) could be a good stock pick from a technical perspective. SWAV surpassed resistance

By GlobeNewsWire
October 26, 2023

Shockwave Medical Announces Details for Conference Call Discussing Third Quarter 2023 Results and Participation in Upcoming Investor Conference

SANTA CLARA, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of t

By Seeking Alpha
August 8, 2023

Shockwave Medical: Not Worth The Price

Shockwave Medical Inc. is a medical device developer focusing on calcified cardiovascular disease treatments, with a promising market opportunity. SWA

By Zacks Investment Research
August 8, 2023

Shockwave Medical (SWAV) Q2 Earnings Miss, Revenues Surge Y/Y

Shockwave Medical's (SWAV) second-quarter results reflect robust revenue growth and gross margin expansion on the back of strong demand and new launch

By The Motley Fool
August 8, 2023

Why Shockwave Medical Stock Dropped Today

Shockwave Medical's Q2 results exceeded revenue expectations but fell short on earnings. The bottom-line shortfall came amid acquisition expenses and

By Zacks Investment Research
August 7, 2023

Shockwave Medical (SWAV) Misses Q2 Earnings Estimates

Shockwave Medical (SWAV) came out with quarterly earnings of $0.76 per share, missing the Zacks Consensus Estimate of $0.87 per share. This compares t

By Zacks Investment Research
July 7, 2023

Reasons to Retain ShockWave Medical (SWAV) in Your Portfolio

ShockWave Medical (SWAV) continues to benefit from solid R&D endeavors and its commitment to clinical studies.

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.